Content Type: Research Publications

Biosimilar Approval Pathways: Comparing the Roles of Five Medicines Regulators

March 6, 2026

State Coverage and Reimbursement of Antiobesity Medications in Medicaid

March 6, 2026

Clinical Value of Molecular Targets and FDA-Approved Genome-Targeted Cancer Therapies

March 6, 2026

Estimated Spending on Beremagene Geperpavec for Dystrophic Epidermolysis Bullosa

March 6, 2026

Biologic Patent Challenges Under the America Invents Act

March 6, 2026

Administrative Action on Drug Pricing: Lessons and Opportunities for the Center for Medicare and Medicaid Innovation

March 6, 2026

Delivery Device Patents on GLP-1 Receptor Agonists

March 6, 2026

The Constitutionality of Medicare Drug-Price Negotiation Under the Takings Clause

March 6, 2026

Patents on Risk Evaluation and Mitigation Strategies for Prescription Drugs and Generic Competition

March 6, 2026

Patient Out-Of-Pocket Costs for Biologic Drugs After Biosimilar Competition

March 6, 2026

Use of Efficiency Frontiers to Align Prices and Clinical Benefits of Biologic Therapies for Plaque Psoriasis

March 6, 2026

Rates and Costs of Drug Testing Practices for Private Payors in the Outpatient Setting in the United States, 2015-2019

March 6, 2026